Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGSS
1951
DELISTED
Pegasus Digital Mobility Acquisition Corp.
PGSS
| $2.94M | ﹤0.01% |
286,226
| – | – |
|
1952
PUT
Coupang
CPNG
$29.2B
| $2.94M | ﹤0.01% |
+200,000
| New | +$3.53M |
|
1953
LCI Industries
LCII
$2.65B
| $2.93M | ﹤0.01% |
31,742
-4,986
| -14% | -$489K |
|
1954
Radian Group
RDN
$4.91B
| $2.93M | ﹤0.01% |
153,872
+50,513
| +49% | +$983K |
|
1955
Iridium Communications
IRDM
$5.29B
| $2.93M | ﹤0.01% |
57,079
-7,700
| -12% | -$387K |
|
1956
Antero Resources
AR
$10.7B
| $2.93M | ﹤0.01% |
94,470
-20,539
| -18% | -$710K |
|
1957
Burford Capital
BUR
$968M
| $2.93M | ﹤0.01% |
359,042
-228,674
| -39% | -$1.89M |
|
1958
CareDx
CDNA
$2.42B
| $2.91M | ﹤0.01% |
254,984
+68,900
| +37% | +$1.02M |
|
1959
Allegro MicroSystems
ALGM
$8.16B
| $2.91M | ﹤0.01% |
96,859
+16,681
| +21% | +$455K |
|
1960
World Kinect Corp
WKC
$1.86B
| $2.9M | ﹤0.01% |
106,240
+81,913
| +337% | +$2.2M |
|
1961
Viridian Therapeutics
VRDN
$2.67B
| $2.9M | ﹤0.01% |
99,320
-554,431
| -85% | -$12.8M |
|
1962
Rambus
RMBS
$11B
| $2.9M | ﹤0.01% |
80,973
+29,733
| +58% | +$1.01M |
|
1963
SPX Corp
SPXC
$10.8B
| $2.89M | ﹤0.01% |
44,077
+3,555
| +9% | +$233K |
|
1964
SoFi Technologies
SOFI
$23.7B
| $2.89M | ﹤0.01% |
626,855
-183,162
| -23% | -$908K |
|
|
CSR
1965
Centerspace
CSR
$952M
| $2.88M | ﹤0.01% |
49,133
+4,178
| +9% | +$270K |
|
1966
Krystal Biotech
KRYS
$9.66B
| $2.88M | ﹤0.01% |
36,348
+3,217
| +10% | +$239K |
|
1967
ICICI Bank
IBN
$108B
| $2.88M | ﹤0.01% |
131,406
-7,313
| -5% | -$163K |
|
1968
Home BancShares
HOMB
$6.18B
| $2.87M | ﹤0.01% |
125,730
+77,955
| +163% | +$1.89M |
|
|
NEE.PRP
1969
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
| $2.86M | ﹤0.01% |
56,505
-78,090
| -58% | -$3.92M |
|
|
AQUA
1970
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $2.86M | ﹤0.01% |
72,133
+40,755
| +130% | +$1.6M |
|
1971
GATX Corp
GATX
$6.27B
| $2.86M | ﹤0.01% |
26,849
+10,953
| +69% | +$1.14M |
|
1972
CALL
Capri Holdings
CPRI
$1.74B
| $2.85M | ﹤0.01% |
+49,800
| New | +$2.52M |
|
1973
Wheaton Precious Metals
WPM
$60.9B
| $2.84M | ﹤0.01% |
72,557
-66,115
| -48% | -$2.39M |
|
1974
Shoals Technologies Group
SHLS
$1.5B
| $2.83M | ﹤0.01% |
114,893
+72,749
| +173% | +$1.76M |
|
|
NBIS
1975
Nebius Group N.V.
NBIS
$47.7B
| $2.83M | ﹤0.01% |
149,231
| – | – |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.